author-photo

Todd Covey

Stanford University

52

Papers

457

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Pharmacodynamic analysis of BTK inhibition in patients with chronic lymphocytic leukemia treated with acalabrutinib

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Discovery of quinoline-based irreversible BTK inhibitors

2020 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (4)
High Surface Expression of CD49d (VLA-4) and CD79b Correlates with Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia (CLL)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 42-Month Follow-up of a Phase 2 Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Acalabrutinib with Obinutuzumab in Relapsed/Refractory and Treatment-Naive Patients with Chronic Lymphocytic Leukemia: The Phase 1b/2 ACE-CL-003 Study

2017 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 4797: The combination of ACP-196 and ACP-319 leads to increased survival in the TCL1-192 CLL mouse model

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Méthodes de traitement de cancers, de maladies immunes et auto-immunes et de maladies inflammatoires fondées sur les taux d'occupation et de re-synthèse de btk

2016
Show All
- Source
- Cite
- Save
Citations (0)
nejmoa1509981 appendix (1)

2016
Show All
- Source
- Cite
- Save
Citations (0)